Syndopa
✅ Relieves Parkinson’s symptoms
✅ Increases dopamine levels
✅ Improves motor function
✅ Reduces tremors
✅ Enhances mobility
Syndopa contains Levodopa and Carbidopa.
✓ Medicinskt granskad av Morgan Ellis — Apoteksforskare · 8 års erfarenhet · Senast granskad: maj 2026
⚡ Quick Answer
Syndopa är en immediate-release combination tablet of levodopa + carbidopa (110 mg (100/10) and 275 mg (250/25)) — the cornerstone treatment for Parkinson disease. Levodopa is converted to dopamine in the brain to replace what failing nigral neurones can no longer make; carbidopa blocks that conversion outside the brain so more levodopa reaches the central nervous system, with fewer peripheral side effects (nausea, vomiting, postural drops). Available in two strengths: 110 mg = 100 mg levodopa + 10 mg carbidopa (the lower carbidopa formula), and 275 mg = 250 mg levodopa + 25 mg carbidopa. The 25 mg carbidopa version is preferred for most patients because 75–100 mg of carbidopa daily is needed to fully saturate peripheral decarboxylase — below that level, peripheral side effects (nausea, hypotension) are common. Critical: never stop levodopa abruptly — risk of neuroleptic malignant-like syndrome. Dose must be tapered.
📦 Varje beställning omfattas av vår Reshipment Assurance Policy — om din försändelse inte anländer inom 20 arbetsdagar, skickar vi om den.
Varför beställa från MedsBase
Våra generiska läkemedel kommer från WHO-GMP-certifierade tillverkare och skickas världsvidt i diskreta, enkla förpackningar — inget läkemedelsnamn på försändelsens utsida. Kortbetalningar hanteras via en reglerad betalningsprocessor (kontoutdrag visar en reglerad kortbetalningsprocessor — aldrig “MedsBase” eller något läkemedelsnamn). Krypto och SEPA-banköverföring accepteras också. Varje beställning backas upp av vår Reshipment Assurance Policy.
What Is Syndopa?
Syndopa is an oral tablet containing levodopa + carbidopa 110 mg (100/10) and 275 mg (250/25) i en immediate-release formulation. The combination has been the foundation of Parkinson disease therapy since the 1970s and remains the most effective single treatment for motor symptoms (bradykinesia, rigidity, tremor). It was originally marketed as Sinemet. Syndopa is manufactured by a WHO-GMP certified facility and is bioequivalent to the originator brand at the same strength.
How Does Syndopa Work?
Parkinson disease results from progressive loss of dopamine-producing neurones in the substantia nigra. Levodopa is the immediate biochemical precursor of dopamine; unlike dopamine itself, it crosses the blood–brain barrier. Once inside the brain, surviving neurones decarboxylate it to dopamine, restoring synaptic dopamine levels and improving motor control.
The problem: when levodopa is given alone, >95% is converted to dopamine in peripheral tissues before it reaches the brain — causing severe nausea, vomiting and orthostatic hypotension, and forcing the use of huge doses. Carbidopa is a peripheral aromatic-amino-acid decarboxylase inhibitor. It does not cross the blood–brain barrier itself, but blocks the breakdown of levodopa in peripheral tissues. The result: a 4–5-fold reduction in the levodopa dose needed for the same brain effect, and far fewer GI/cardiovascular side effects.
Who Is Syndopa For?
Syndopa is appropriate for adults with idiopathic Parkinson disease who need symptomatic motor relief, including:
- Newly diagnosed patients in whom symptoms interfere with daily function (older patients especially — in younger patients, neurologists often start with a dopamine agonist or MAO-B inhibitor first to delay levodopa-related dyskinesia).
- Patients on a dopamine agonist or MAO-B inhibitor whose symptoms have progressed and who now need additional motor benefit.
- Patients needing rapid symptom relief — immediate-release levodopa reaches peak plasma concentration in 30–60 minutes, ideal for the first morning dose to break early-morning akinesia.
- As an “on top” rescue for breakthrough symptoms in patients otherwise on controlled-release.
- Some patients with parkinsonism due to other causes (post-encephalitic, manganese intoxication, certain atypical syndromes) — under specialist guidance, with the understanding that response is usually less robust than in idiopathic PD.
Not appropriate for: patients with narrow-angle glaucoma, suspected melanoma or undiagnosed skin lesion, severe psychotic disorder, or current use of a non-selective MAO inhibitor (within 14 days).
Dosing and Administration
| Phase | Typical schedule | Anteckningar |
|---|---|---|
| Initiation | Half (or whole) 110 mg or 275 mg tablet 3 times daily with food | Smaller doses if nausea-prone or older |
| Titration (weekly) | Increase by half a tablet (or one whole 110 mg) every 2–7 days | Until adequate symptom control or side effects develop |
| Typical maintenance | 300–1000 mg levodopa/day in 3–5 divided doses | Plus 75–100 mg carbidopa/day minimum |
| Maximum | Practical limit ~2000 mg levodopa/day; rarely needed | Higher doses cause peak-dose dyskinesia |
Syndopa is the immediate-release formulation. Onset of action within 30–60 minutes; peak effect at 1–1.5 hours; duration 3–5 hours per dose in early disease, shortening to 2–3 hours as disease progresses. The first dose of the day is usually the most important — many patients take it before getting out of bed (with a small snack such as a biscuit) to break early-morning akinesia.
Long-Term Issues: Motor Fluctuations and Dyskinesia
After 5–10 years of levodopa therapy, many patients develop:
- Wearing-off — each dose lasts a shorter time; symptoms return before the next dose. Managed by shorter dose intervals, adding a COMT inhibitor (entacapone) or MAO-B inhibitor (rasagiline, safinamide).
- On–off phenomena — sudden unpredictable swings between mobile (“on”) and rigid (“off”) states.
- Dyskinesia — involuntary writhing or twisting movements at peak levodopa concentration. Managed by reducing each individual dose, adding amantadine, or changing the formulation.
- Freezing of gait — brief inability to start or continue walking. Less responsive to medication; physical-therapy strategies (visual cues, rhythmic music) often help more.
These problems are easier to delay than to treat once established — one reason younger patients are sometimes started on dopamine agonists or MAO-B inhibitors first.
Vanliga biverkningar
Early in treatment: nausea, vomiting, anorexia, postural hypotension, dizziness, dry mouth. Most settle within 2–4 weeks. Taking with food or domperidone helps.
With long-term use: dyskinesia (peak-dose involuntary movements), motor fluctuations (wearing-off, on–off), hallucinations, vivid dreams, impulse-control disorders (less common than with dopamine agonists), insomnia, sudden-onset sleep, harmless reddish-brown discolouration of urine and sweat.
Mindre vanliga: confusion, paranoia, depression, mania, gambling/hypersexuality, neuroleptic malignant-like syndrome on abrupt withdrawal.
Drug and Food Interactions
- Non-selective MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) — contraindicated. Stop 14 days before starting levodopa.
- Dopamine antagonists — metoclopramide, prochlorperazine, haloperidol, risperidone, olanzapine: pharmacological antagonism. Use domperidone for nausea, quetiapine or clozapine for psychosis (under specialist care).
- Antihypertensiva läkemedel — additive postural hypotension.
- Iron salts — chelate levodopa in the gut. Separate doses by at least 2 hours.
- High-protein meals — large neutral amino acids compete for transport across the blood–brain barrier. Time doses 30 min before or 1 h after protein-rich food in fluctuating patients.
- Pyridoxine (vitamin B6) >10 mg/day — only relevant if levodopa is given without carbidopa. Combination products are protected.
Vanliga frågor
Why is levodopa combined with carbidopa?
Carbidopa blocks the conversion of levodopa to dopamine in peripheral tissues, so far more reaches the brain. This reduces nausea, vomiting and blood-pressure drops, and lowers the effective levodopa dose by about 75%.
Should I take an immediate-release or controlled-release levodopa?
Immediate-release (Syndopa) is preferred when rapid onset is needed — the first morning dose, and breakthrough doses for sudden “off” periods. Controlled-release (Syndopa CR) is preferred for steadier all-day levels and for the bedtime dose to prevent overnight stiffness. Many patients on advanced therapy use a mix — an IR dose to start the day, CR for daytime smoothness, and IR top-ups for breakthrough symptoms. Your neurologist will tailor the combination.
Why does my urine turn dark on this medication?
Levodopa and its metabolites can give urine, sweat and saliva a harmless reddish-brown or rust colour. Some clothing stains may persist. This is not a sign of a kidney or liver problem and does not need investigation.
Can I take Syndopa with food?
In the first weeks, take with a small meal or snack to reduce nausea. Once on stable therapy, especially if you have wearing-off, take levodopa 30 min before or 1 h after a protein-rich meal — protein competes for absorption.
What is “wearing-off”?
After several years of levodopa therapy, each dose lasts a progressively shorter time and motor symptoms return before the next dose. This is wearing-off. It is managed by shorter dose intervals, adding a COMT inhibitor (entacapone) or MAO-B inhibitor (rasagiline, safinamide), or switching some doses to controlled-release.
What is “dyskinesia”?
Dyskinesia is involuntary writhing, twisting or rocking movement that occurs at the peak of the levodopa dose — the patient is “over-medicated” for that moment. It is managed by reducing each dose (and giving more frequent smaller doses), adding amantadine, or other strategies. Counterintuitively, it is a sign that the drug is working.
Can I stop Syndopa abruptly?
No. Sudden withdrawal can trigger a neuroleptic-malignant-like syndrome — fever, rigidity, confusion, autonomic instability. Tapering must be planned with your neurologist. If you cannot take it orally (e.g. surgery), ask about a rotigotine patch as a bridge.
Will Syndopa make me drowsy or cause “sleep attacks”?
Levodopa can cause daytime somnolence and, rarely, sudden-onset sleep without warning. Risk is higher when combined with a dopamine agonist. Until you know how you respond, do not drive long distances or operate heavy machinery.
Can Syndopa cause hallucinations or compulsive behaviours?
Yes — though both are more common with dopamine agonists than with levodopa. Visual hallucinations are most common, especially in older patients and those with cognitive impairment. New gambling, shopping, sexual or eating behaviours should be reported to your neurologist promptly. Reducing the dose or simplifying the regimen usually helps.
Can I take Syndopa during surgery or hospital admission?
Levodopa should ideally be continued through surgery. Tell the surgical team in advance. If you cannot swallow tablets, your team will arrange a feeding tube, transdermal rotigotine, or subcutaneous apomorphine. Do not let the drug be skipped for “NPO” reasons without a substitute — abrupt withdrawal is dangerous.
How does MedsBase ship Syndopa?
Worldwide shipping in discreet packaging from a WHO-GMP certified manufacturer. Tablets are shipped in original sealed blister packs. Track your order from your MedsBase account.
Förvaring
Store at room temperature (15–30°C / 59–86°F), protected from heat, moisture and direct light. Keep in the original container with the lid tightly closed. Keep out of reach of children. Do not use beyond the expiry date printed on the packaging.
Medicinsk ansvarsfriskrivning
This information is provided for educational purposes only and is not a substitute for the advice of a qualified clinician. Parkinson disease and parkinsonian syndromes require individualised neurology care. Discuss all medications, supplements and pre-existing conditions with your doctor before starting, changing or stopping treatment. Do not abruptly discontinue dopaminergic therapy — sudden withdrawal can precipitate a neuroleptic malignant-like syndrome.
Relaterade alternativ
Andra produkter inom Kroniska tillstånd som kunder även tittar på:
More options in Parkinson's Disease Treatment
Rangerade efter senaste ordervolym på MedsBase — vad andra kunder i denna kategori väljer.
| Styrka | 110 mg, 275 mg |
|---|---|
| Kvantitet | 30 tabletter, 60 tabletter, 90 tabletter, 180 tabletter |
Syndopa
Frågor & svar
Syndopa
Relaterade produkter
Recensioner
Det finns inga recensioner än